KIDNEASE
LIVE

Serial Number

97257499

Owner

SP Nutraceuticals, Inc.

Attorney

Darren Spielman

Filing Date

Feb 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

KIDNEASE Trademark

Serial Number: 97257499

KIDNEASE is a trademark filed by SP Nutraceuticals, Inc. on February 8, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

SP Nutraceuticals, Inc. (9 trademarks)

Burlington L7L5H6 , CA

Entity Type: 03

Trademark Details

Filing Date

February 8, 2022

Registration Date

Not Registered

Goods & Services

Botanical herbal and dietary supplements for treatment and prevention of nephrolithiasis; dietary supplements for treatment and prevention of nephrolithiasis; herbal supplements for treatment and prevention of nephrolithiasis; nutritional supplements for treatment and prevention of nephrolithiasis; botanical herbal and dietary supplements for treatment and prevention of symptoms associated with urinary tract infections; dietary supplements for treatment and prevention of symptoms associated with urinary tract infections; herbal supplements for treatment and prevention of symptoms associated with urinary tract infections; nutritional supplements for treatment and prevention of symptoms associated with urinary tract infections; botanical herbal and dietary supplements for general health and well-being; dietary supplements for general health and well-being; herbal supplements for general health and well-being; nutritional supplements for general health and well-being

Filing History

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 13, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 13, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 13, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 24, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 23, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 23, 2025 GNSL
SUSPENSION LETTER WRITTEN
Apr 23, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 8, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Apr 2, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Apr 2, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Apr 2, 2025 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 10, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 10, 2024 GNSL
SUSPENSION LETTER WRITTEN
Sep 10, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2024 CRFA
ASSIGNED TO LIE
Sep 9, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 16, 2024 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 18, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 18, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 18, 2024 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 13, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 13, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jul 13, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 31, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 30, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 30, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 30, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 30, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 30, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 21, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 14, 2022 NWOS
NEW APPLICATION ENTERED
Feb 11, 2022 NWAP